Mucormycosis extending from the surgical wound to the transplanted kidney: Case report and literature review

Experimental and Clinical Transplantation

Volumn 10, Issue 4, 2012, Pages 403-405

  Zhao, Liang ^a   Wang, Chang Xi ^a   Zhang, Ling ^a   Tu, Xiang An ^a   Wang, Wenwei ^a   Chen, Yu ^a   Liu, Long Shan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Kidney transplant; Mucormycosis; Nephrectomy; Polymerase chain reaction

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; CASE REPORT; DEBRIDEMENT; DIAGNOSTIC ACCURACY; GRAFT RECIPIENT; GRAFT REJECTION; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MUCORMYCOSIS; NEPHRECTOMY; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; REVIEW; SPECIES IDENTIFICATION; SUBCUTANEOUS TISSUE; SURGICAL WOUND;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BIOPSY; DEBRIDEMENT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MUCORALES; MUCORMYCOSIS; NECROSIS; NEPHRECTOMY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; REOPERATION; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 84865082620     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2011.0107     Document Type: Review

References (14)

1. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009;48(12):1743-1751.
2. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18(3):556-569.
3. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634-653.
4. Schwarz P, Bretagne S, Gantier JC, et al. Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol. 2006;44(2):340-349.
5. Chakrabarti A. Cutaneous zygomycosis: major concerns. Indian J Med Res. 2010;131:739-741.
6. Skiada A, Petrikkos G. Cutaneous zygomycosis. Clin Microbiol Infect. 2009;15(suppl 5):41-45.
7. Gabardi S, Kubiak DW, Chandraker AK, Tullius SG. Invasive fungal infections and antifungal therapies in solid organ transplant recipients. Transpl Int. 2007;20(12):993-1015.
8. Stelzmueller I, Lass-Floerl C, Geltner C, et al. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients. Transpl Int. 2008;21(6):534-546.
9. Page AV, Evans AJ, Snell L, Liles WC. Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature. Transpl Infect Dis. 2008;10(6):419-425.
10. Cavrini F, Stanzani M, Liguori G, Sambri V. Identification of an invasive infection of R. oryzae in a haematological patient using a molecular technique. Mycoses. 2010;53(3):269-271.
11. Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis. 2006;25(4):215-229.
12. Perfect JR. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis. 2005;40(suppl 6):S401-S408.
13. van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006;42(7):e61-e65. Erratum in: Clin Infect Dis. 2006;43(10):1376.
14. Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006;50(1):126-133.